Literature DB >> 6295445

Phosphorus-31 nuclear magnetic resonance studies of the two phosphoserine residues of hen egg white ovalbumin.

H J Vogel, W A Bridger.   

Abstract

Ovalbumin contains two phosphoserine residues that give rise to two well-resolved resonances in a 31P NMR spectrum. Ovalbumin samples that have been digested with a variety of phosphatases may give rise to only one phosphoserine resonance, indicating that one of the two phosphorylated sites is relatively inaccessible for phosphatase action. By comparison of the amino acid sequence of the peptide containing the nonsusceptible phosphate to the overall primary structure, we have assigned the resonances observed (pH 8.3) at 5.0 and 4.75 ppm to phosphoserines-68 and -344, respectively. pH titration behavior and susceptibility of the phosphoserine residues to phosphatases indicate that both are located on the surface of the protein. Both residues have a pKa = 6.00-6.04. Analysis of the Hill coefficients measured for the pH titrations and the JPH coupling constants indicate that neither residue interacts with other charged groups on the surface of the protein. Frequency dependence of 31P NMR parameters shows that at higher magnetic field strengths the contribution of chemical shift anisotropy to the line width becomes very significant. We have calculated from the field-dependent terms that phosphoserine-344 is mobile with respect to the protein surface but that phosphoserine-68 is more restricted in its motion. The latter is also involved in a pH-dependent conformational change, since it is shielded from hydrolysis by phosphatases at higher pH. A comparison of the amino acid sequence of the phosphoserine-68 site shows that it has a striking homology to the active-site peptides of a wide variety of hydrolytic enzymes. Moreover, a comparison with the primary sequences of casein suggests that both proteins are phosphorylated by a protein kinase that specifically recognizes a Ser-X-Glu peptide.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6295445     DOI: 10.1021/bi00266a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Large-scale purification and characterization of the major phosphoproteins and mucins of human submandibular-sublingual saliva.

Authors:  N Ramasubbu; M S Reddy; E J Bergey; G G Haraszthy; S D Soni; M J Levine
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

2.  Modulation of conformational equilibrium by phosphorylation underlies the activation of deubiquitinase A.

Authors:  Ashish Kabra; Efsita Rumpa; Ying Li
Journal:  J Biol Chem       Date:  2020-02-18       Impact factor: 5.157

3.  Ovalbumin and angiotensinogen lack serpin S-R conformational change.

Authors:  P E Stein; D A Tewkesbury; R W Carrell
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

4.  S-ovalbumin, an ovalbumin conformer with properties analogous to those of loop-inserted serpins.

Authors:  J A Huntington; P A Patston; P G Gettins
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

5.  Multisite phosphorylation disrupts arginine-glutamate salt bridge networks required for binding of cytoplasmic linker-associated protein 2 (CLASP2) to end-binding protein 1 (EB1).

Authors:  Praveen Kumar; Michael S Chimenti; Hayley Pemble; André Schönichen; Oliver Thompson; Matthew P Jacobson; Torsten Wittmann
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

6.  Effects of PKA phosphorylation on the conformation of the Na,K-ATPase regulatory protein FXYD1.

Authors:  Peter Teriete; Khang Thai; Jungyuen Choi; Francesca M Marassi
Journal:  Biochim Biophys Acta       Date:  2009-09-15

7.  OGlcNAcylation and phosphorylation have similar structural effects in α-helices: post-translational modifications as inducible start and stop signals in α-helices, with greater structural effects on threonine modification.

Authors:  Michael B Elbaum; Neal J Zondlo
Journal:  Biochemistry       Date:  2014-04-03       Impact factor: 3.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.